Today: 20 December 2025
Subscribe
Browse Category

Investment Analysis News 13 December 2025 - 14 December 2025

City Developments (CDL) Stock Update: SGX:C09 Rises on Bullish Broker Calls, Asset Recycling Focus — Outlook for This Week and Week Ahead (Updated 14 Dec 2025)

City Developments (CDL) Stock Update: SGX:C09 Rises on Bullish Broker Calls, Asset Recycling Focus — Outlook for This Week and Week Ahead (Updated 14 Dec 2025)

City Developments Limited (CDL) shares ended the latest trading week higher after a fresh wave of bullish sell-side commentary lifted sentiment across Singapore property developers. CDL’s stock (SGX: C09) last closed at S$7.34 on Friday, 12 Dec 2025, up 1.8%
14 December 2025
 ·  ·  ·  · 
Brambles Limited (ASX: BXB) Stock Update: Buyback Momentum, Share Price Moves, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Brambles Limited (ASX: BXB) Stock Update: Buyback Momentum, Share Price Moves, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Updated: Sunday, 14 December 2025 (AEST) Brambles Limited (ASX: BXB) heads into the new trading week with attention firmly on one theme: capital returns via its on‑market share buy‑back—and the steady drip of ASX filings showing how many shares are
14 December 2025
 ·  ·  ·  · 
South32 Ltd (ASX: S32) Stock: Buyback Shrinks Share Count, Hermosa Water Probe Grabs Headlines, and What to Watch This Week (Updated 14 Dec 2025)

South32 Ltd (ASX: S32) Stock: Buyback Shrinks Share Count, Hermosa Water Probe Grabs Headlines, and What to Watch This Week (Updated 14 Dec 2025)

South32 Ltd stock (ASX: S32) heads into the new trading week with a busy mix of catalysts: an ongoing on‑market share buyback, a newly completed divestment in Colombia, boardroom changes, and fresh scrutiny around the company’s Hermosa project in Arizona.
14 December 2025
 ·  ·  ·  · 
Westpac (ASX: WBC) Share Price: This Week’s Moves, Latest News, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Westpac (ASX: WBC) Share Price: This Week’s Moves, Latest News, Analyst Forecasts and the Week Ahead (Updated 14 Dec 2025)

Updated: 14 December 2025 (Sunday) — Australian markets last traded on Friday, 12 December. markets.ft.markitdigital.com Westpac Banking Corporation’s shares ended the week on a firmer note, but the story behind the ticker has been less about a single macro headline
14 December 2025
 ·  ·  ·  · 
Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings Ltd. (NYSE: NU) — the parent of Nubank — closed Friday, Dec. 12, 2025 at about $16.90, ending a steadier week after early-December volatility. Investing.com For investors tracking NU stock into next week, the story is less about
14 December 2025
 ·  ·  ·  ·  · 
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close). Destiny Tech100 Inc. (NYSE: DXYZ) just posted a sharp, high-volume run-up as investor attention snapped back to one theme: SpaceX IPO speculation—and what it could mean for public-market “access” vehicles tied to private
14 December 2025
 ·  ·  ·  ·  · 
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage
14 December 2025
 ·  ·  ·  ·  · 
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at
14 December 2025
 ·  ·  ·  ·  · 
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58
13 December 2025
 ·  ·  ·  · 
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the
13 December 2025
 ·  ·  ·  ·  · 
1 … 36 37 38 39 40 … 153
Go toTop